HomeNGNE • NASDAQ
add
Neurogene Inc
Previous close
$19.75
Day range
$19.65 - $20.63
Year range
$6.88 - $74.49
Market cap
285.30M USD
Avg Volume
120.84K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.72M | 26.34% |
Net income | -22.02M | -19.06% |
Net profit margin | — | — |
Earnings per share | -1.05 | — |
EBITDA | -25.31M | -31.05% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 274.52M | 78.37% |
Total assets | 297.32M | 65.34% |
Total liabilities | 24.06M | -3.02% |
Total equity | 273.26M | — |
Shares outstanding | 14.27M | — |
Price to book | 1.03 | — |
Return on assets | -21.29% | — |
Return on capital | -22.19% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -22.02M | -19.06% |
Cash from operations | -19.46M | -22.46% |
Cash from investing | 7.45M | 131.55% |
Cash from financing | 54.00K | -86.47% |
Net change in cash | -11.96M | 69.42% |
Free cash flow | -11.65M | -23.92% |
About
Founded
2018
Website
Employees
107
